ES8609468A1 - Un procedimiento para preparar un derivado de una enzima fibronolitica - Google Patents
Un procedimiento para preparar un derivado de una enzima fibronoliticaInfo
- Publication number
- ES8609468A1 ES8609468A1 ES539000A ES539000A ES8609468A1 ES 8609468 A1 ES8609468 A1 ES 8609468A1 ES 539000 A ES539000 A ES 539000A ES 539000 A ES539000 A ES 539000A ES 8609468 A1 ES8609468 A1 ES 8609468A1
- Authority
- ES
- Spain
- Prior art keywords
- enzyme
- preparation
- pharmaceutical use
- protein conjugate
- fibrinolytic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PREPARACION DE UN DERIVADO DE UNA ENZIMA FIBRINOLITICA. SE HACE REACCIONAR UNA PROTEINA HUMANA OPCIONALMENTE MODIFICADA PARA INCLUIR UN GRUPO DE UNION A LA PROTEINA CON UNA ENZIMA FIBRINOLITICA Y CON UN AGENTE ENLAZANTE QUE TIENE UN RESTO CAPAZ DE REACCIONAR CON EL SITIO CATALITICO DE LA ENZIMA Y UN RESTO CAPAZ DE REACCIONAR CON UN GRUPO AMINO DE UNA PROTEINA O UN GRUPO DE UNION A LA PROTEINA PARA FORMAR UN GRUPO ENLAZANTE REVERSIBLE. EL SITIO CATALITICO DE LA ENZIMA RESPONSABLE DE LA ACCION FIBRINOLITICA ESTA BLOQUEADO POR UNA PROTEINA HUMANA UNIDA A ELLA POR UN GRUPO ENLAZANTE REVERSIBLE QUE LE CONFIERE ACTIVIDAD PARA SU EMPLEO EN ENFERMEDADES TROMBOTICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838334499A GB8334499D0 (en) | 1983-12-24 | 1983-12-24 | Derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8609468A1 true ES8609468A1 (es) | 1986-09-01 |
ES539000A0 ES539000A0 (es) | 1986-09-01 |
Family
ID=10553871
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES539000A Expired ES8609468A1 (es) | 1983-12-24 | 1984-12-21 | Un procedimiento para preparar un derivado de una enzima fibronolitica |
ES546739A Expired ES8605476A1 (es) | 1983-12-24 | 1985-09-05 | Un procedimiento para preparar un derivado de acido benzoico. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES546739A Expired ES8605476A1 (es) | 1983-12-24 | 1985-09-05 | Un procedimiento para preparar un derivado de acido benzoico. |
Country Status (12)
Country | Link |
---|---|
US (3) | US4600580A (es) |
EP (2) | EP0283563B1 (es) |
JP (1) | JPH0829085B2 (es) |
AU (1) | AU580747B2 (es) |
CA (1) | CA1271718A (es) |
DE (2) | DE3484655D1 (es) |
ES (2) | ES8609468A1 (es) |
GB (1) | GB8334499D0 (es) |
GR (1) | GR82558B (es) |
MX (1) | MX7663E (es) |
NZ (1) | NZ210696A (es) |
ZA (1) | ZA849927B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5650270A (en) * | 1982-02-01 | 1997-07-22 | Northeastern University | Molecular analytical release tags and their use in chemical analysis |
US4880776A (en) * | 1983-12-24 | 1989-11-14 | Beecham Group P.L.C. | Plasmin A-chain urokinase B-chain hybrid protein |
GB8334499D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Derivatives |
GB8334498D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Compounds |
GB8400653D0 (en) * | 1984-01-11 | 1984-02-15 | Beecham Group Plc | Conjugates |
GB8430253D0 (en) * | 1984-11-30 | 1985-01-09 | Beecham Group Plc | Compounds |
US4916070A (en) * | 1986-04-14 | 1990-04-10 | The General Hospital Corporation | Fibrin-specific antibodies and method of screening for the antibodies |
GB8707369D0 (en) * | 1987-03-27 | 1987-04-29 | Beecham Group Plc | Enzyme derivatives |
US5217705A (en) * | 1987-09-25 | 1993-06-08 | Neorx Corporation | Method of diagnosing blood clots using fibrin-binding proteins |
US5151359A (en) * | 1988-05-19 | 1992-09-29 | Mitsui Toatsu Chemicals Incorporated | Method for producing of human tissue type plasminogen activator |
US5811265A (en) * | 1988-08-19 | 1998-09-22 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
US5609869A (en) * | 1988-08-19 | 1997-03-11 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
US5183754A (en) * | 1988-10-04 | 1993-02-02 | Mitsui Toatsu Chemicals, Incorporated | Method for production of human tissue type plasminogen activator |
US5272076A (en) * | 1991-06-13 | 1993-12-21 | Eli Lilly And Company | Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA |
US6608204B1 (en) * | 1994-12-13 | 2003-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
JP2001504813A (ja) * | 1996-10-21 | 2001-04-10 | クウォドラント、ヘルスケアー、(ユーケー)、リミテッド | 代用血小板、及びそれらの製造に適した抱合法 |
CA2280866A1 (en) * | 1997-02-13 | 1998-08-20 | Lxr Biotechnology Inc. | Organ preservation solution |
WO2004082640A2 (en) * | 2003-03-19 | 2004-09-30 | New Century Pharmaceuticals, Inc. | Human serum albumin conjugates with therapeutic compounds |
US7541159B2 (en) * | 2004-04-14 | 2009-06-02 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Molecular-specific urokinase antibodies |
US10878790B1 (en) | 2020-03-13 | 2020-12-29 | Aspire Precision Instruments, LLC | Device and method for amplitude modulated optical pickup for a stringed instrument |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US428593A (en) * | 1890-05-27 | Sleigh | ||
US4464468A (en) * | 1968-03-29 | 1984-08-07 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immobilization of active protein by cross-linking to inactive protein |
GB1463513A (en) * | 1974-08-13 | 1977-02-02 | Beecham Group Ltd | Enzymes |
CS181417B1 (en) * | 1975-03-27 | 1978-03-31 | Miroslav Bleha | Method for preparing insoluble biologically active compounds |
DE2621974A1 (de) * | 1976-05-18 | 1977-11-24 | Max Planck Gesellschaft | Verfahren zur herstellung eines zur kovalenten bindung mit biologisch aktivem material befaehigten traegermaterials |
US4082612A (en) * | 1976-09-24 | 1978-04-04 | Michael Reese Research Foundation | Plasminogen activator complex |
US4134792A (en) * | 1976-12-06 | 1979-01-16 | Miles Laboratories, Inc. | Specific binding assay with an enzyme modulator as a labeling substance |
SE427505B (sv) * | 1977-03-04 | 1983-04-11 | Pharmacia Diagnostics Ab | Reagens till anvendning vid immunkemiska bestemningsmetoder |
SE430062B (sv) * | 1977-03-04 | 1983-10-17 | Pharmacia Fine Chemicals Ab | Kopplings- eller tioleringsreagens |
US4233401A (en) * | 1977-07-14 | 1980-11-11 | Syva Company | Antienzyme homogeneous competitive binding assay |
US4275000A (en) * | 1977-08-22 | 1981-06-23 | National Research Development Corporation | Peptide macromolecular complexes |
NZ191320A (en) * | 1978-09-07 | 1982-09-14 | Beecham Group Ltd | In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions |
SE446184B (sv) * | 1979-01-12 | 1986-08-18 | Toyo Jozo Kk | Polyfunktionell disulfidforening anvendbar som tverbindande medel |
US4305926A (en) * | 1979-09-13 | 1981-12-15 | Johannes Everse | Immobilization of Streptokinase |
US4286964A (en) * | 1979-10-12 | 1981-09-01 | Seed Brian S | Polyfunctional epoxides and halohydrins used as bridging groups to bind aromatic amine group-containing alcohols and thiols to hydroxyl bearing substrates |
FR2470773B1 (es) * | 1979-11-28 | 1983-01-28 | Pasteur Institut | |
NL8003402A (nl) * | 1980-06-11 | 1982-01-04 | Leuven Res & Dev Vzw | Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking. |
SE450834B (sv) * | 1980-11-19 | 1987-08-03 | Biocompat Inc | Sett att binda ett protein till en berare innehallande hydroxylgrupper |
SE8102193L (sv) * | 1981-04-06 | 1982-10-07 | Pharmacia Ab | Terapeutiskt aktiv organisk forening och dess anvendning |
US4429008B1 (en) * | 1981-12-10 | 1995-05-16 | Univ California | Thiol reactive liposomes |
EP0091240B1 (en) * | 1982-04-07 | 1985-12-27 | Beecham Group Plc | Enzyme derivatives, process for preparing them and pharmaceutical compositions containing them |
US4536391A (en) * | 1982-11-17 | 1985-08-20 | Otsuka Pharmaceutical Co. | Process for preparing urokinase complex |
GB8334499D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Derivatives |
GB8400653D0 (en) * | 1984-01-11 | 1984-02-15 | Beecham Group Plc | Conjugates |
US4542225A (en) * | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
-
1983
- 1983-12-24 GB GB838334499A patent/GB8334499D0/en active Pending
-
1984
- 1984-12-13 EP EP87115581A patent/EP0283563B1/en not_active Expired - Lifetime
- 1984-12-13 DE DE8787115581T patent/DE3484655D1/de not_active Expired - Fee Related
- 1984-12-13 DE DE8484115346T patent/DE3477469D1/de not_active Expired
- 1984-12-13 EP EP84115346A patent/EP0155388B1/en not_active Expired
- 1984-12-20 ZA ZA849927A patent/ZA849927B/xx unknown
- 1984-12-20 MX MX8411401U patent/MX7663E/es unknown
- 1984-12-21 CA CA000470956A patent/CA1271718A/en not_active Expired - Fee Related
- 1984-12-21 US US06/684,359 patent/US4600580A/en not_active Expired - Fee Related
- 1984-12-21 ES ES539000A patent/ES8609468A1/es not_active Expired
- 1984-12-21 GR GR82558A patent/GR82558B/el unknown
- 1984-12-21 AU AU37072/84A patent/AU580747B2/en not_active Ceased
- 1984-12-21 NZ NZ210696A patent/NZ210696A/xx unknown
- 1984-12-24 JP JP59272693A patent/JPH0829085B2/ja not_active Expired - Lifetime
-
1985
- 1985-09-05 ES ES546739A patent/ES8605476A1/es not_active Expired
-
1987
- 1987-04-03 US US07/034,784 patent/US4730050A/en not_active Expired - Fee Related
- 1987-04-15 US US07/039,114 patent/US4741903A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0283563B1 (en) | 1991-05-29 |
GB8334499D0 (en) | 1984-02-01 |
NZ210696A (en) | 1989-04-26 |
ES546739A0 (es) | 1986-03-16 |
JPS60178864A (ja) | 1985-09-12 |
ES8605476A1 (es) | 1986-03-16 |
US4730050A (en) | 1988-03-08 |
EP0155388B1 (en) | 1989-03-29 |
EP0155388A3 (en) | 1986-12-10 |
EP0283563A3 (en) | 1988-11-23 |
EP0283563A2 (en) | 1988-09-28 |
US4600580A (en) | 1986-07-15 |
AU3707284A (en) | 1985-07-04 |
ZA849927B (en) | 1986-04-30 |
GR82558B (en) | 1985-04-23 |
EP0155388A2 (en) | 1985-09-25 |
MX7663E (es) | 1990-06-19 |
DE3477469D1 (en) | 1989-05-03 |
US4741903A (en) | 1988-05-03 |
AU580747B2 (en) | 1989-02-02 |
ES539000A0 (es) | 1986-09-01 |
JPH0829085B2 (ja) | 1996-03-27 |
CA1271718A (en) | 1990-07-17 |
DE3484655D1 (de) | 1991-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8609468A1 (es) | Un procedimiento para preparar un derivado de una enzima fibronolitica | |
EP0152736A3 (en) | Enzyme-protein conjugate, process for its preparation and pharmaceutical composition | |
MY114889A (en) | 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity | |
MY101593A (en) | Sustained release preparation. | |
PT82575B (fr) | Procede de preparation d'un produit conjugue constitue d'une adhesine de s.mutans de nature proteique d'une composition a activite immunogene et d'un polysaccharide de s.mutans et son utilisation notamment dans des vaccins anti-caries | |
AU649605B2 (en) | Retinal, derivatives and their therapeutic use | |
AU1917095A (en) | 6-substituted mycophenolic and derivatives with immunosuppressive activity | |
NO891380D0 (no) | Anti-inflammatorisk hudfuktingspreparat og fremgangsmaate for fremstilling derav. | |
AU1916995A (en) | 4-amino derivatives of mycophenolic acid with immunosuppressant activity | |
EP0211592A3 (en) | Pharmaceutical dosage unit | |
EP0233013A3 (en) | Modified enzyme | |
DK159652C (da) | Cholecalciferolderivater, disse derivater til brug som terapeutisk aktive substanser, fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat baseret paa disse cholecalciferolderivater | |
NO854942L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive, benzotiofener og benzofuraner. | |
NO862534L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser. | |
BG50159A3 (en) | Method for preparing derivatives of piranobenzadiasole | |
BG44709A3 (bg) | Метод за получаване на 9-хлор-1,5-бензотиазепинови производни | |
IT8423896A0 (it) | Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche. | |
AU8282187A (en) | 5-hydroxyethyl derivatives of oxazolidinone-2, their preparation and their therapeutic uses | |
EP0270682A4 (en) | NEW COMPLEXES, PROCESS FOR THEIR PREPARATION, AND THEIR MEDICINAL USE. | |
HU912742D0 (en) | T-pa pro-stabilization | |
EP0184363A3 (en) | Enzyme conjugates and their therapeutical use | |
NO168055C (no) | Fremgangsmaate for fremstilling av human vevplasminogenaktivator og urokinase-type plasminogenaktivator. | |
NO166280C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer. | |
ATE4637T1 (de) | Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel. | |
AU2695588A (en) | Peptides, a process for the preparation thereof, the use thereof for obtaining antibodies, and the use thereof for blocking pai 1 activity in human blood |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |
Effective date: 19960506 |